These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

178 related items for PubMed ID: 8964856

  • 1. The effect of one-year cross-sex hormonal treatment on bone metabolism and serum insulin-like growth factor-1 in transsexuals.
    van Kesteren P, Lips P, Deville W, Popp-Snijders C, Asscheman H, Megens J, Gooren L.
    J Clin Endocrinol Metab; 1996 Jun; 81(6):2227-32. PubMed ID: 8964856
    [Abstract] [Full Text] [Related]

  • 2. Long-term follow-up of bone mineral density and bone metabolism in transsexuals treated with cross-sex hormones.
    van Kesteren P, Lips P, Gooren LJ, Asscheman H, Megens J.
    Clin Endocrinol (Oxf); 1998 Mar; 48(3):347-54. PubMed ID: 9578826
    [Abstract] [Full Text] [Related]

  • 3. Cortical and trabecular bone mineral density in transsexuals after long-term cross-sex hormonal treatment: a cross-sectional study.
    Ruetsche AG, Kneubuehl R, Birkhaeuser MH, Lippuner K.
    Osteoporos Int; 2005 Jul; 16(7):791-8. PubMed ID: 15502960
    [Abstract] [Full Text] [Related]

  • 4. High serum IGFBP-2 is predictive of increased bone turnover in aging men and women.
    Amin S, Riggs BL, Melton LJ, Achenbach SJ, Atkinson EJ, Khosla S.
    J Bone Miner Res; 2007 Jun; 22(6):799-807. PubMed ID: 17352648
    [Abstract] [Full Text] [Related]

  • 5. Comparison of effects of the rise in serum testosterone by raloxifene and oral testosterone on serum insulin-like growth factor-1 and insulin-like growth factor binding protein-3.
    Duschek EJ, Gooren LJ, Netelenbos C.
    Maturitas; 2005 Jul 16; 51(3):286-93. PubMed ID: 15978972
    [Abstract] [Full Text] [Related]

  • 6. Effects of suppression of estrogen action by the p450 aromatase inhibitor letrozole on bone mineral density and bone turnover in pubertal boys.
    Wickman S, Kajantie E, Dunkel L.
    J Clin Endocrinol Metab; 2003 Aug 16; 88(8):3785-93. PubMed ID: 12915670
    [Abstract] [Full Text] [Related]

  • 7. Recombinant human insulin-like growth factor I, recombinant human growth hormone, and sex steroids: effects on markers of bone turnover in humans.
    Mauras N, Doi SQ, Shapiro JR.
    J Clin Endocrinol Metab; 1996 Jun 16; 81(6):2222-6. PubMed ID: 8964855
    [Abstract] [Full Text] [Related]

  • 8. Deficiency in androgens and upregulation of insulin-like growth factor-1 are involved in high bone turnover in men receiving androgen deprivation therapy for prostate cancer.
    Ishizaki F, Hara N, Takizawa I, Nishiyama T, Isahaya E, Kawasaki T, Takahashi K.
    Growth Horm IGF Res; 2012 Jun 16; 22(3-4):122-8. PubMed ID: 22579549
    [Abstract] [Full Text] [Related]

  • 9. Effects of intranasal 17beta-estradiol on bone turnover and serum insulin-like growth factor I in postmenopausal women.
    Garnero P, Tsouderos Y, Marton I, Pelissier C, Varin C, Delmas PD.
    J Clin Endocrinol Metab; 1999 Jul 16; 84(7):2390-7. PubMed ID: 10404809
    [Abstract] [Full Text] [Related]

  • 10. Serum levels of insulin-like growth factor binding proteins (IGFBP)-4 and -5 correlate with bone mineral density in growth hormone (GH)-deficient adults and increase with GH replacement therapy.
    Thorén M, Hilding A, Brismar T, Magnusson P, Degerblad M, Larsson L, Sääf M, Baylink DJ, Mohan S.
    J Bone Miner Res; 1998 May 16; 13(5):891-9. PubMed ID: 9610754
    [Abstract] [Full Text] [Related]

  • 11. Serum levels of insulin-like growth factor system components and relationship to bone metabolism in Type 1 and Type 2 diabetes mellitus patients.
    Jehle PM, Jehle DR, Mohan S, Böhm BO.
    J Endocrinol; 1998 Nov 16; 159(2):297-306. PubMed ID: 9795371
    [Abstract] [Full Text] [Related]

  • 12. The growth hormone/insulin-like growth factor-I axis hormones and bone markers in elite athletes in response to a maximum exercise test.
    Ehrnborg C, Lange KH, Dall R, Christiansen JS, Lundberg PA, Baxter RC, Boroujerdi MA, Bengtsson BA, Healey ML, Pentecost C, Longobardi S, Napoli R, Rosén T, GH-2000 Study Group.
    J Clin Endocrinol Metab; 2003 Jan 16; 88(1):394-401. PubMed ID: 12519882
    [Abstract] [Full Text] [Related]

  • 13. Serum insulin-like growth factor-I, insulin-like growth factor binding proteins, and bone mineral content in hyperthyroidism.
    Lakatos P, Foldes J, Nagy Z, Takacs I, Speer G, Horvath C, Mohan S, Baylink DJ, Stern PH.
    Thyroid; 2000 May 16; 10(5):417-23. PubMed ID: 10884189
    [Abstract] [Full Text] [Related]

  • 14. A potentially deleterious role of IGFBP-2 on bone density in aging men and women.
    Amin S, Riggs BL, Atkinson EJ, Oberg AL, Melton LJ, Khosla S.
    J Bone Miner Res; 2004 Jul 16; 19(7):1075-83. PubMed ID: 15176989
    [Abstract] [Full Text] [Related]

  • 15. Analysis of bone mineral density and turnover in patients with cystic fibrosis: associations between the IGF system and inflammatory cytokines.
    Street ME, Spaggiari C, Ziveri MA, Volta C, Federico G, Baroncelli GI, Bernasconi S, Saggese G.
    Horm Res; 2006 Jul 16; 66(4):162-8. PubMed ID: 16804317
    [Abstract] [Full Text] [Related]

  • 16. Serum insulin-like growth factor-I, insulin-like growth factor binding protein-3, sex steroids, osteocalcin and bone mineral density in male and female rats.
    Fukuda R, Usuki S, Mukai N, Amagai H, Hayashi K, Takamatsu K.
    Gynecol Endocrinol; 1998 Oct 16; 12(5):297-305. PubMed ID: 9859021
    [Abstract] [Full Text] [Related]

  • 17. Effect of sex hormone replacement on the insulin-like growth factor system and bone mineral: a cross-sectional and longitudinal study in 595 perimenopausal women participating in the Danish Osteoporosis Prevention Study.
    Vestergaard P, Hermann AP, Orskov H, Mosekilde L.
    J Clin Endocrinol Metab; 1999 Jul 16; 84(7):2286-90. PubMed ID: 10404791
    [Abstract] [Full Text] [Related]

  • 18. The relationship between bone turnover and body weight, serum insulin-like growth factor (IGF) I, and serum IGF-binding protein levels in patients with anorexia nervosa.
    Hotta M, Fukuda I, Sato K, Hizuka N, Shibasaki T, Takano K.
    J Clin Endocrinol Metab; 2000 Jan 16; 85(1):200-6. PubMed ID: 10634387
    [Abstract] [Full Text] [Related]

  • 19. Changes in the serum growth factors and osteoprotegerin after bone marrow transplantation: impact on bone and mineral metabolism.
    Baek KH, Lee WY, Oh KW, Kim HS, Han JH, Kang MI, Cha BY, Lee KW, Son HY, Kang SK, Kim CC.
    J Clin Endocrinol Metab; 2004 Mar 16; 89(3):1246-54. PubMed ID: 15001618
    [Abstract] [Full Text] [Related]

  • 20. Effects of recombinant human growth hormone on metabolic indices, body composition, and bone turnover in healthy elderly women.
    Holloway L, Butterfield G, Hintz RL, Gesundheit N, Marcus R.
    J Clin Endocrinol Metab; 1994 Aug 16; 79(2):470-9. PubMed ID: 7519191
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.